Special Issue: Resistance to Targeted Therapies in Human Cancer

Biomedicines. 2023 Jan 31;11(2):414. doi: 10.3390/biomedicines11020414.

Tae-Won Lee¹, Hee-Joo Choi^{2

3

4}, Kyung-Min Lee^{1

4

5

6}, Jeong-Yeon Lee^{2

4}

¹ Department of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, Republic of Korea.
² Department of Pathology, College of Medicine, Hanyang University, Seoul 04763, Republic of Korea.
³ Hanyang Biomedical Research Institute, Hanyang University, Seoul 04763, Republic of Korea.
⁴ Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul 04763, Republic of Korea.
⁵ Research Institute for Natural Sciences, Hanyang University, Seoul 04763, Republic of Korea.
⁶ Research Institute for Convergence of Basic Sciences, Hanyang University, Seoul 04763, Republic of Korea.

Abstract

Cancer is the second leading cause of death worldwide, accounting for approximately 10 million deaths in 2020 [...].